Takeda Norifumi | Department Of Cardiology The Sakakibara Heart Institute

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Pulmonary Thromboembolism in a Patient With an Anomalous Right Coronary Artery as a Cause of Unusual Biventricular Myocardial Infarction
OJ-259 Acyclic Retinoid Inhibits Neointima Formation through Retinoic Acid Receptor Beta-induced Apoptosis(Cardiovascular pharmacology, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
OE-299 Acyclic Retinoid is a Possible Oral Therapeutic Agent against Neointimal Hyperplasia(Cardiovascular pharmacology, basic/clinical-1 (H) OE50,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Socie
Acyclic Retinoid Prevents Cardiovascular Remodeling by Regulated KLF5(Cardiovascular Pharmacology, Basic/Clinical 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Chronic Advanced Pulmonary Hypertension
Takayasu Myocarditis Mediated by Cytotoxic T Lymphocytes
4 Bone marrow-derived cells contribute to vascular wall inflammation without differentiating into smooth muscle cells(Young Investigator's Award Finalists Lectures (YIA),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
OE-273 Acyclic Retinoid Regulates KLF5 And Inhibits Cardiovascular Remodeling(Cardiovascular Pharmacology, Basic/Clinical 1 (H) : OE34)(Oral Presentation (English))
DPE-071 Retinoic Acid Receptor Antagonist Ameliorates Pressure Overload-Induced Cardiac Hypertrophy and Remodeling(DPE12,Cardiomyopathy/Hypertrophy (Basic) (M),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
FRS-093 Significance of the Transcription Factor KLF5 in Myocardial Hypertrophy in Response to Pressure Overload(FRS19,Genetic Abnormalities in Cardiac Hypertrophy and Cardiomyopathy (M),Featured Research Session (English),The 73rd Annual Scientific Meeti
FRS-079 Rad51 Plays a Pivotal Role in Adipose Tissue Obesity and Systemic Insulin Resistance(FRS16,Basic Mechanisms of Lipid Disorders and Metabolic Syndrome (H),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circul
PJ-412 S100A8 and S100A9 are novel proinflammatory signal mediators in cardiovascular and metabolic disease(Atherosclerosis, basic(07)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-256 Significance of the Transcription Factor KLF5 in Myocardial Hypertrophy in Response to Pressure Overload(Cardiac hypertrophy, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-235 Identification of Metabolic Syndrome Related-unknown Key Molecule With Using siRNA Library(Metabolism/Biochemistry/Energetics(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
FRS-093 KLF5 controls fibrosis in cardiovascular and kidney diseases via S100 protein expression(Renal Dysfunction and Cardiovascular Disease(H),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Infective Endocarditis Associated with Quadricuspid Aortic Valve
Adrenomedullin Possesses Novel Angiogenic Properties with Reduction of Vascular Permeability And Edema(Angiogenesis 5 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Adrenomedullin Possesses Novel Angiogenic Properties Mediated by Its Ability to Enhance Expression And Signaling Pathway of VEQF(Angiogenesis 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
PE-392 Modulator of KLF5 activity is a useful tool for therapeutic angiogenesis(Angiogenesis 4 (IHD) : PE67)(Poster Session (English))
OJ-325 Regulation of cardiovascular remodeling by inhibitor of PDGF receptor tyrosine kinase(Cardiovascular Pharmacology, Basic/Clinical 2 (H) : OJ39)(Oral Presentation (Japanese))
OE-319 KLF5 inhibitor, Am80, reduces adipose tissue growth and fatty liver disease in leptin-deficient (ob/ob) mice.(Diabetes/Obesity 2 (H) : OE40)(Oral Presentation (English))
OE-291 Novel Angiogenic Properties of Adrenomedullin in Ischemia, Tumor Growth and Development(Genetics/Genetically Engineered Models 2 (H) : OE36)(Oral Presentation (English))
OE-290 Accelerated Cardiac Hypertrophy under Stress in Adrenomedullin Knockout Mice through PKA and PKC Pathway(Genetics/Genetically Engineered Models 2 (H) : OE36)(Oral Presentation (English))
OE-114 Kruppel-like Zinc-finger Transcription Factor KLF5/BTEB2 is an Essential Regulator of Cardiovascular Remodeling(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
FRS-095 KLF5 inhibitor Am80 reduces atherosclerosis in apolipoprotein E-knockout mice.(Inflammation and Cardiovascular Disease (IHD) : FRS12)(Featured Research Session (English))
Accelerated Cardiac Hypertrophy and Renal Damage Induced by Angiotensin II in Adrenomedullin Knockout Mice
Normalization of Left Ventricular Parameters Following Combined Pimobendan and Carvedilol Treatment in a Case of Unclassified Cardiomyopathy with Longstanding Refractory Status
Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis-Retrospective analysis of 11 case histories
Circulating Transforming Growth Factor β-1 Level in Japanese Patients With Marfan Syndrome
Chronic Advanced Pulmonary Hypertension
Subarachnoid Hemorrhage from Mycotic Aneurysms

もっと見る

スポンサーリンク